Literature DB >> 28698300

Kinetochores accelerate or delay APC/C activation by directing Cdc20 to opposing fates.

Taekyung Kim1,2, Pablo Lara-Gonzalez1,2, Bram Prevo1,2, Franz Meitinger1,2, Dhanya K Cheerambathur1,2, Karen Oegema1,2, Arshad Desai1,2.   

Abstract

Mitotic duration is determined by activation of the anaphase-promoting complex/cyclosome (APC/C) bound to its coactivator, Cdc20. Kinetochores, the microtubule-interacting machines on chromosomes, restrain mitotic exit when not attached to spindle microtubules by generating a Cdc20-containing complex that inhibits the APC/C. Here, we show that flux of Cdc20 through kinetochores also accelerates mitotic exit by promoting its dephosphorylation by kinetochore-localized protein phosphatase 1, which allows Cdc20 to activate the APC/C. Both APC/C activation and inhibition depend on Cdc20 fluxing through the same binding site at kinetochores. The microtubule attachment status of kinetochores therefore optimizes mitotic duration by controlling the balance between opposing Cdc20 fates.
© 2017 Kim et al.; Published by Cold Spring Harbor Laboratory Press.

Entities:  

Keywords:  APC/C; Cdc20; cell division; kinetochore; protein phosphatase 1; spindle assembly checkpoint

Mesh:

Substances:

Year:  2017        PMID: 28698300      PMCID: PMC5538432          DOI: 10.1101/gad.302067.117

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


Genome stability requires that cells spend sufficient time in mitosis to align and segregate their chromosomes with high accuracy. Mitotic duration is determined by the lag between activation of Cdk1–cyclin B and full activation of the anaphase-promoting complex/cyclosome (APC/C), an E3 ubiquitin ligase. The APC/C ubiquitinates and targets for degradation securin and cyclin B, thereby triggering anaphase onset and mitotic exit (Barford 2011). During mitosis, APC/C activity requires the essential cofactor Cdc20. Phosphorylation of APC/C subunits by Cdk1 promotes APC/C activation by enhancing the affinity of Cdc20 for the APC/C (Fujimitsu et al. 2016; Qiao et al. 2016; Zhang et al. 2016). However, Cdk phosphorylation of Cdc20 also negatively regulates its ability to bind to and activate the APC/C (Kramer et al. 2000; Yudkovsky et al. 2000; Labit et al. 2012; Hein and Nilsson 2016). Thus, Cdc20 dephosphorylation during mitosis has the potential to be a control point that regulates the timing of APC/C activation and therefore the duration of the mitotic phase of the cell cycle. Cdc20 is also central to the spindle assembly checkpoint, a mechanism that promotes accurate chromosome segregation by delaying anaphase onset until all of the kinetochores, the microtubule-binding machines of mitotic chromosomes (Cheeseman 2014; Musacchio and Desai 2017), have established attachments to spindle microtubules. At unattached kinetochores, the spindle checkpoint pathway—comprised of the Bub1/Bub3 complex, the Mad1/Mad2 complex, Mad3 (known as BubR1 in vertebrates and Drosophila), and the kinases Mps1 and Plk1—generates a diffusible complex containing Cdc20 that inhibits the APC/C (Lara-Gonzalez et al. 2012; Musacchio 2015). Cdc20 exhibits kinetochore localization that is conserved in fungi, Drosophila, and vertebrates (Kallio et al. 2002; Li et al. 2010; Yang et al. 2015). Recruitment of Cdc20 depends on the kinetochore-localized components Bub1 and BubR1 (Li et al. 2010; Di Fiore et al. 2015), which share a common Cdc20 interaction motif known as the ABBA motif or Phe box (Diaz-Martinez et al. 2015; Di Fiore et al. 2015). However, the contribution of Cdc20 kinetochore localization to its roles in activating and/or inhibiting the APC/C has remained unclear. In prior work, it was found that the kinetochore-localized Bub1/Bub3 complex, which is central to spindle checkpoint signaling, paradoxically promotes anaphase onset via a mechanism that can be uncoupled from the checkpoint (Kim et al. 2015; Yang et al. 2015). Here, we show that Cdc20 rapidly fluxes through kinetochores in a Bub1 ABBA motif-dependent manner. This localized flux facilitates APC/C activation by promoting removal of inhibitory Cdk phosphorylation on Cdc20 by kinetochore-localized protein phosphatase 1 (PP1). Notably, flux of Cdc20 through the same binding site is also required for checkpoint-mediated APC/C inhibition when kinetochores are unattached. These results indicate that kinetochores optimize mitotic duration by channeling Cdc20 into opposing fates, with the balance between them controlled by microtubule attachment.

Results and Discussion

To define the role of kinetochore-localized Cdc20 in controlling mitotic duration, we used the first mitotic division of the Caenorhabditis elegans embryo as a model system. As in other species, CDC-20 (also known as FZY-1) (Kitagawa et al. 2002) localized to the kinetochores of C. elegans holocentric chromosomes between prometaphase and early anaphase (Fig. 1A; Supplemental Movies S1, 2). In contrast, no kinetochore localization was observed for an in situ tagged essential APC/C subunit (Apc1MAT-2) (Supplemental Fig. S1A), indicating that kinetochore-localized CDC-20 is not bound to the APC/C. Depletion of the kinetochore component BUB-1 prevented CDC-20 kinetochore localization (Fig. 1B), consistent with prior work in mammalian cells (Di Fiore et al. 2015; Jia et al. 2016). Fluorescence recovery after photobleaching (FRAP) experiments revealed that the population of CDC-20 at kinetochores is highly dynamic, with a half-life of 1.2 sec (Fig. 1C); in contrast, neither BUB-1 nor the outer kinetochore scaffold protein KNL-1, to which the BUB-1/BUB-3 complex binds, exhibited rapid turnover (Fig. 1C; data not shown). Fast Cdc20 turnover at kinetochores is also observed in human cells (Kallio et al. 2002), indicating that rapid flux of Cdc20 through kinetochores is widely conserved.
Figure 1.

BUB-1 promotes APC/C activation and is required to recruit a dynamic CDC-20 pool to the kinetochore. (A) Images from a time-lapse sequence of the indicated GFP fusions in embryos also coexpressing mCherry(mCh)::H2b. Bar, 5 µm. (B) Metaphase images (top) and quantification (bottom) of GFP::CDC-20 chromosomal fluorescence for the indicated conditions. Error bars are the 95% confidence interval. (****) P < 0.0001 (Mann-Whitney test). Bar, 2 µm. (C) FRAP analysis. (Top) Metaphase images of GFP::CDC-20-expressing or KNL-1::GFP-expressing embryos. Time 0 indicates the first bleached frame. (Bottom) Quantification of GFP fluorescence. Error bars are the 95% confidence interval. Bar, 1 µm. (D) Images from time-lapse sequences (left) and quantification of the nuclear envelope breakdown (NEBD)–anaphase onset interval (right) for the indicated conditions. Time below panels is in seconds relative to NEBD. P-values are from Mann-Whitney test. Bar, 5 µm. (E) Quantification of the NEBD–anaphase onset interval for the indicated conditions. Imaging was performed at 22°C, at which the Apc8MAT-3 temperature-sensitive mutant is viable. (****) P < 0.0001 (Mann-Whitney test). (F) Plot of normalized Cyclin B::mNeongreen (mNG) fluorescence for the indicated conditions. Error bars are the 95% confidence interval; anaphase onset times are indicated. See also Supplemental Figure S1.

BUB-1 promotes APC/C activation and is required to recruit a dynamic CDC-20 pool to the kinetochore. (A) Images from a time-lapse sequence of the indicated GFP fusions in embryos also coexpressing mCherry(mCh)::H2b. Bar, 5 µm. (B) Metaphase images (top) and quantification (bottom) of GFP::CDC-20 chromosomal fluorescence for the indicated conditions. Error bars are the 95% confidence interval. (****) P < 0.0001 (Mann-Whitney test). Bar, 2 µm. (C) FRAP analysis. (Top) Metaphase images of GFP::CDC-20-expressing or KNL-1::GFP-expressing embryos. Time 0 indicates the first bleached frame. (Bottom) Quantification of GFP fluorescence. Error bars are the 95% confidence interval. Bar, 1 µm. (D) Images from time-lapse sequences (left) and quantification of the nuclear envelope breakdown (NEBD)–anaphase onset interval (right) for the indicated conditions. Time below panels is in seconds relative to NEBD. P-values are from Mann-Whitney test. Bar, 5 µm. (E) Quantification of the NEBD–anaphase onset interval for the indicated conditions. Imaging was performed at 22°C, at which the Apc8MAT-3 temperature-sensitive mutant is viable. (****) P < 0.0001 (Mann-Whitney test). (F) Plot of normalized Cyclin B::mNeongreen (mNG) fluorescence for the indicated conditions. Error bars are the 95% confidence interval; anaphase onset times are indicated. See also Supplemental Figure S1. BUB-1 is required for flux of the APC/C activator CDC-20 through kinetochores, and prior work in C. elegans and Saccharomyces cerevisiae has shown that the kinetochore-localized Bub1/Bub3 complex promotes anaphase onset (Kim et al. 2015; Yang et al. 2015), suggesting a potential link between these two phenomena. In the one-cell C. elegans embryo, BUB-1 depletion increased the interval between nuclear envelope breakdown (NEBD) and anaphase onset by ∼50% (Fig. 1D); this increase was unaffected by removal of the checkpoint component MAD-3 (Fig. 1D) and was also observed in a bub-3 deletion (Kim et al. 2015). Two pieces of evidence indicate that BUB-1 depletion delayed anaphase onset by compromising APC/C activation. First, BUB-1 depletion exhibited a genetic interaction with a temperature-sensitive mutation in the essential APC/C subunit Apc8MAT-3 [mat-3(or344); referred to as Apc8] (Rappleye et al. 2002). BUB-1 depletion and the Apc8 mutation each delayed anaphase onset by ∼50%; by comparison, when the two perturbations were combined, anaphase onset was delayed by ∼200% (Fig. 1E; Supplemental Movie S3). Second, BUB-1 depletion slowed degradation of the APC/C substrate Cyclin B (CYB-1) (Fig. 1F; Supplemental Fig. S1B,C), whereas depletion of the checkpoint component MAD-2 had no effect (Supplemental Fig. S1D), indicating that mitotic duration is not controlled by the spindle checkpoint during this division. To determine whether the role of BUB-1 in promoting APC/C activation was related to CDC-20 kinetochore recruitment, we specifically altered the ability of BUB-1 to bind CDC-20. C. elegans BUB-1 has a potential CDC-20-interacting ABBA motif (Fig. 2A; Supplemental Fig. S2A), and a yeast two-hybrid assay confirmed that this motif mediates interaction with CDC-20 (Fig. 2B). Using a targeted RNAi-resistant transgene integration system (Moyle et al. 2014), we replaced endogenous BUB-1 with either wild-type or ABBA mutant BUB-1 at endogenous expression levels (Fig. 2C). The BUB-1 ABBA mutant significantly reduced CDC-20 kinetochore localization and delayed anaphase onset to an extent similar to BUB-1 depletion (Fig. 2D,E; Supplemental Movie S4). Moreover, the delay in anaphase onset cause by the BUB-1 ABBA mutant was significantly enhanced in the presence of the Apc8 mutant (Supplemental Fig. S2B; Supplemental Movie S5). These results indicate that CDC-20 recruitment to kinetochores by the BUB-1 ABBA motif promotes anaphase onset.
Figure 2.

The ABBA motif of BUB-1 recruits CDC-20 to both promote APC/C activation and generate a checkpoint signal at unattached kinetochores. (A) Schematic of BUB-1 and its conserved ABBA motif. Alanine mutations introduced in the ABBA motif are indicated. (B) Yeast two-hybrid analysis of a BUB-1 fragment that interacts with both CDC-20 and BUB-3. (C) Immunoblots of transgene-encoded BUB-1 (wild-type [WT] or ABBA mutant [Mut]) and endogenous CDC-20 in the absence of endogenous BUB-1. A dilution curve of wild-type (N2) worms is on the same blot for comparison. α-Tubulin served as a loading control. The asterisk denotes residual CDC-20 signal after reblotting. (D) Metaphase images (top) and quantification (bottom) of GFP::CDC-20 chromosomal fluorescence for the indicated conditions. Error bars are the 95% confidence interval. (****) P < 0.0001 (Mann-Whitney test). Bar, 2 µm. (E) Images from time-lapse sequences (left) and quantification of the NEBD–anaphase onset interval (right) of embryos expressing GFP::H2b for the indicated conditions. Time below panels is seconds relative to NEBD. (****) P < 0.0001 (Mann-Whitney test). Bar, 5 µm. (F) Quantification of checkpoint signaling in two-cell embryos in the presence of unattached kinetochores for the indicated conditions. Mitotic duration is the NEBD–chromosome decondensation interval. (****) P < 0.0001 (Mann-Whitney test). (G) Schematic summarizing two opposing fates of CDC-20 that is fluxing through kinetochores via interaction with the ABBA motif of BUB-1. (H) Embryo viability analysis for the indicated conditions. At least 14 worms and 2330 embryos were scored per condition. Error bars represent the standard deviation. See also Supplemental Figure S2.

The ABBA motif of BUB-1 recruits CDC-20 to both promote APC/C activation and generate a checkpoint signal at unattached kinetochores. (A) Schematic of BUB-1 and its conserved ABBA motif. Alanine mutations introduced in the ABBA motif are indicated. (B) Yeast two-hybrid analysis of a BUB-1 fragment that interacts with both CDC-20 and BUB-3. (C) Immunoblots of transgene-encoded BUB-1 (wild-type [WT] or ABBA mutant [Mut]) and endogenous CDC-20 in the absence of endogenous BUB-1. A dilution curve of wild-type (N2) worms is on the same blot for comparison. α-Tubulin served as a loading control. The asterisk denotes residual CDC-20 signal after reblotting. (D) Metaphase images (top) and quantification (bottom) of GFP::CDC-20 chromosomal fluorescence for the indicated conditions. Error bars are the 95% confidence interval. (****) P < 0.0001 (Mann-Whitney test). Bar, 2 µm. (E) Images from time-lapse sequences (left) and quantification of the NEBD–anaphase onset interval (right) of embryos expressing GFP::H2b for the indicated conditions. Time below panels is seconds relative to NEBD. (****) P < 0.0001 (Mann-Whitney test). Bar, 5 µm. (F) Quantification of checkpoint signaling in two-cell embryos in the presence of unattached kinetochores for the indicated conditions. Mitotic duration is the NEBD–chromosome decondensation interval. (****) P < 0.0001 (Mann-Whitney test). (G) Schematic summarizing two opposing fates of CDC-20 that is fluxing through kinetochores via interaction with the ABBA motif of BUB-1. (H) Embryo viability analysis for the indicated conditions. At least 14 worms and 2330 embryos were scored per condition. Error bars represent the standard deviation. See also Supplemental Figure S2. We next determined whether perturbing CDC-20 kinetochore localization affected spindle checkpoint activation at unattached kinetochores. In C. elegans embryos, spindle checkpoint activity is analyzed by triggering the assembly of monopolar spindles with unattached kinetochores at the two-cell stage, which increases mitotic duration by ∼60% (Essex et al. 2009). Notably, at the permissive temperature in the Apc8 mutant, the same perturbation increases mitotic duration by ∼500%, significantly improving the sensitivity of checkpoint signaling analysis (Supplemental Fig. S2C–F; Supplemental Movie S6). Using this sensitive assay, we found that the BUB-1 ABBA mutant failed to activate the checkpoint in the presence of unattached kinetochores (Fig. 2F; Supplemental Movie S7) even though MAD-1 enrichment at unattached kinetochores was unaffected (Supplemental Fig. S2G). A requirement for the BUB-1 ABBA motif in spindle checkpoint signaling has also been reported in human cells (Di Fiore et al. 2015). Thus, CDC-20 recruited by the ABBA motif of BUB-1 to kinetochores has the ability to both promote anaphase onset and, when kinetochores are persistently unattached, delay anaphase onset (Fig. 2G). While the BUB-1 ABBA mutant rescued the lethality of a bub-1 deletion (Supplemental Fig. S2H), it was synthetic-lethal in combination with the mild reduction in APC/C function caused by Apc8. At 22°C, Apc8 and the BUB-1 ABBA mutant on their own supported viability of >97% of embryos; in contrast, only 3% of embryos generated by the double mutant were viable (Fig. 2H). Notably, the synthetic lethality observed in the double mutant was not associated with loss of checkpoint signaling in the BUB-1 ABBA mutant, as it was not observed when the mad-3 deletion, which is checkpoint signaling-defective, was combined with Apc8 (Supplemental Fig. S2I). Thus, recruitment of CDC-20 by the ABBA motif is required for kinetochore-localized BUB-1 to accelerate APC/C activation, and this acceleration becomes essential for embryo viability when APC/C activity is mildly compromised. Next, we focused on addressing how CDC-20 fluxing through the kinetochore is altered to accelerate APC/C activation. It was shown previously in vitro that the ability of the APC/C coactivators Cdc20 and Cdh1 to bind to and activate the APC/C is inhibited by Cdk1/2-dependent phosphorylation (Kramer et al. 2000; Yudkovsky et al. 2000; Labit et al. 2012). Cdk targeted phosphorylation sites in the Cdc20 N terminus are in the vicinity of the conserved C-box that directly contacts the APC/C subunit Apc8 (Chang et al. 2015; Zhang et al. 2016). Phosphorylation of human Cdc20 by Plk1/Bub1 on Ser92 was also shown to inhibit the recruitment of E2 ubiquitin-conjugating enzymes that promote ubiquitin chain elongation on APC/C substrates (Craney et al. 2016; Jia et al. 2016). However, the function of Cdc20 phosphorylation in a cellular context is currently unclear. C. elegans CDC-20 possesses three putative Cdk sites in its N terminus, which are evolutionarily conserved (note that Ser92 is not conserved outside of vertebrates) (Fig. 3A). To assess whether phosphorylation of these sites controls APC/C activation in vivo, we developed a targeted RNAi-resistant transgene insertion system (Supplemental Fig. S3A–D) to replace endogenous CDC-20 with either wild-type CDC-20 or a triple-alanine (3A) mutant. Strikingly, mutation of the three Cdk sites resulted in embryos racing through mitosis and entering anaphase prior to full chromosome congression (Fig. 3B; Supplemental Fig. S3E; Supplemental Movie S8). The accelerated mitosis phenotype of CDC-20 3A was due to premature APC/C activation, as Cyclin B degradation started concomitantly with NEBD (Fig. 3C). Conversely, a phosphomimetic triple-aspartate (3D) mutant (Supplemental Fig. S3F) resulted in an embryo permeability defect, osmotic sensitivity, and lethality (Supplemental Fig. S3G,H)—phenotypes associated with compromised APC/C function (Rappleye et al. 2002). We confirmed that one or more of the mutated sites are phosphorylated in vivo through phosphorylation-dependent gel mobility shifts and phos tag gels (Fig. 3D–F). Mutation of individual sites indicated that Thr32, which is closest to the C-box and is likely phosphorylated in vivo based on phos tag gel analysis, is the major site whose mutation to alanine is responsible for accelerated APC/C activation (Supplemental Fig. S4A–E). This result is consistent with phosphorylation reducing the affinity of the C-box interaction with the APC/C. A prior study in human cells suggested that Cdc20 N-terminal phosphorylation is mediated by Cyclin A–Cdk2 and promotes mitotic entry (Hein and Nilsson 2016); however, the CDC-20 3A mutant did not alter interphase duration, and depletion of the single C. elegans Cyclin A (CYA-1) did not accelerate mitosis (Supplemental Fig. S4F,G).
Figure 3.

Cdk phosphorylation of CDC-20 restrains APC/C activation. (A) Schematic of CDC-20 structure and alignment highlighting conserved Cdk sites in the N terminus. (B) Images from time-lapse sequences (top) and quantification of the NEBD–anaphase onset interval (bottom) of embryos expressing GFP::H2b for the indicated conditions. Time below panels is in seconds relative to NEBD. (****) P < 0.0001 (Mann-Whitney test). Bar, 5 µm. (C) Plot of normalized Cyclin B::mNeongreen (mNG) fluorescence as in Figure 1C. (D) Immunoblot of endogenous CDC-20 with and without phosphatase treatment. (E) Immunoblot analysis of transgene-encoded CDC-20 (wild type [WT] or 3A) in the absence of endogenous CDC-20. α-Tubulin served as a loading control. Note that the 3A mutant is expressed at a lower level than wild-type CDC-20 but nonetheless accelerates APC/C activation and anaphase onset. (F) Analysis of CDC-20 phospho-isoforms by immunoblotting of a manganese phos tag gel. (G) Embryo viability analysis for the indicated conditions. At least 14 worms and 1300 embryos were scored per condition. (H) Quantification of the NEBD–anaphase onset interval of embryos expressing GFP::H2b for the indicated conditions. (****) P < 0.0001 (Mann-Whitney test). (I) Schematic summarizing the effect on APC/C activation of disrupting kinetochore localization or N-terminal Cdk phosphorylation of CDC-20. See also Supplemental Figures S3 and S4.

Cdk phosphorylation of CDC-20 restrains APC/C activation. (A) Schematic of CDC-20 structure and alignment highlighting conserved Cdk sites in the N terminus. (B) Images from time-lapse sequences (top) and quantification of the NEBD–anaphase onset interval (bottom) of embryos expressing GFP::H2b for the indicated conditions. Time below panels is in seconds relative to NEBD. (****) P < 0.0001 (Mann-Whitney test). Bar, 5 µm. (C) Plot of normalized Cyclin B::mNeongreen (mNG) fluorescence as in Figure 1C. (D) Immunoblot of endogenous CDC-20 with and without phosphatase treatment. (E) Immunoblot analysis of transgene-encoded CDC-20 (wild type [WT] or 3A) in the absence of endogenous CDC-20. α-Tubulin served as a loading control. Note that the 3A mutant is expressed at a lower level than wild-type CDC-20 but nonetheless accelerates APC/C activation and anaphase onset. (F) Analysis of CDC-20 phospho-isoforms by immunoblotting of a manganese phos tag gel. (G) Embryo viability analysis for the indicated conditions. At least 14 worms and 1300 embryos were scored per condition. (H) Quantification of the NEBD–anaphase onset interval of embryos expressing GFP::H2b for the indicated conditions. (****) P < 0.0001 (Mann-Whitney test). (I) Schematic summarizing the effect on APC/C activation of disrupting kinetochore localization or N-terminal Cdk phosphorylation of CDC-20. See also Supplemental Figures S3 and S4. The CDC-20 3A and T32A mutants, while accelerating normal mitosis, retained the ability to significantly delay mitosis in the presence of unattached kinetochores (Supplemental Fig. S4H). This result suggests that the CDC-20 3A and T32A mutants can bind to the BUB-1 ABBA motif and are incorporated into the inhibitory complex generated by the spindle checkpoint at unattached kinetochores. In addition, while CDC-20 3A and T32A supported embryonic viability, they were synthetic-lethal/sick with depletion of the checkpoint component MAD-3 (Fig. 3G; data not shown), suggesting that, in the absence of inhibitory Cdk phosphorylation on CDC-20, mitotic duration is too short for establishment of correct kinetochore–microtubule attachments and requires time provided by the checkpoint for organismal survival. The above observations suggest that CDC-20 is inhibited by Cdk phosphorylation and is dynamically concentrated at kinetochores by the BUB-1 ABBA motif to promote its dephosphorylation (Fig. 3I, left panel). A prediction of this model is that preventing CDC-20 phosphorylation should bypass the role of its kinetochore localization in promoting APC/C activation. In agreement with this prediction, CDC-20 3A or T32A eliminated the delay caused by BUB-1 depletion/the ABBA mutant and made the NEBD–anaphase onset interval equivalent to that observed when only CDC-20 3A or T32A are present (Fig. 3H,I; Supplemental Fig. S4I,J). We next focused on identifying the phosphatase that reverses inhibitory CDC-20 phosphorylation at the kinetochore. In human cells, PP1 and the B56 isoform of PP2A localize to kinetochores (Trinkle-Mulcahy et al. 2003; Foley et al. 2011). To visualize these phosphatases, we engineered in situ tagged GFP fusions of the two essential C. elegans PP1 catalytic (PP1c) subunits (GSP-1 and GSP2) and the two functionally redundant B56 orthologs (PPTR-1 and PPTR-2). The two PP1c orthologs localized to kinetochores with distinct temporal dynamics (Supplemental Fig. S5A). In contrast, no significant kinetochore signal was observed for the functional tagged B56 orthologs (Supplemental Fig. S5B,C). To test whether PP1c acts on CDC-20 at kinetochores to reverse inhibitory Cdk phosphorylation, we used a PP1c-binding mutant of KNL-1 (Fig. 4A; Liu et al. 2010; Espeut et al. 2012), which significantly impaired kinetochore recruitment of both PP1c catalytic subunits (Supplemental Fig. S5D). The PP1c-binding site on KNL-1 is adjacent to a region with so-called “MELT” (Met–Glu–Leu–Thr) repeats that constitute phospho-dependent docking sites for BUB-1/BUB-3 (Fig. 4A; Primorac et al. 2013). Consistent with the idea that PP1c restricts KNL-1 “MELT” phosphorylation to limit BUB-1/BUB-3 kinetochore recruitment (London et al. 2012), significantly higher levels of BUB-1 and CDC-20 were observed at kinetochores in the KNL-1 PP1c-binding mutant (Fig. 4A). Notably, even though BUB-1 and CDC-20 were hyperrecruited to kinetochores, perturbing PP1c kinetochore localization delayed anaphase onset to an extent similar to preventing CDC-20 kinetochore localization by mutating the ABBA motif in BUB-1 (Fig. 4B); this delay was largely checkpoint-independent (Fig. 4B; Espeut et al. 2012). This result suggests that KNL-1-associated PP1c dephosphorylates CDC-20 as it is fluxing through kinetochores. Consistent with this, the CDC-20 3A and T32A phosphorylation mutants abolished the anaphase onset delay caused by the KNL-1 PP1c-binding mutant (Fig. 4C; Supplemental Fig. S5F). In addition, simultaneously perturbing PP1c and CDC-20 kinetochore localization using the KNL-1 PP1c-binding mutant and the BUB-1 ABBA mutant, respectively, (Fig. 4D), or generating a mutant form of KNL-1 that cannot recruit either PP1c or BUB-1/BUB-3 to kinetochores (Supplemental Fig. S5E) did not result in additive delays. Mitotic duration in the double CDC-20/KNL-1 mutants was slightly longer than in the CDC-20 3A or T32A mutants alone (Fig. 4C; Supplemental Fig. S5F) potentially because hyperrecruitment of CDC-20 to kinetochores due to perturbation of PP1c kinetochore localization may reduce its availability for APC/C activation. Taken together, these results suggest that PP1c bound to KNL-1 dephosphorylates CDC-20 dynamically recruited to kinetochores by the BUB-1 ABBA motif, thereby accelerating APC/C activation.
Figure 4.

Kinetochore-localized PP1c is the likely enzyme dephosphorylating CDC-20 fluxing through the kinetochore. (A, top) Schematic of KNL-1 primary structure; the PP1-binding site (SILK–RRVSF), the “MELT” repeats that recruit the BUB-1/BUB-3 complex when phosphorylated, and the mutations engineered in KNL-1 to disrupt PP1c binding (PP1c Mut) are depicted. (Bottom) Images (left) and quantification (right) of chromosomal fluorescence for BUB-1::GFP and GFP::CDC-20 in the indicated conditions. (****) P < 0.0001 (Mann-Whitney test). Bar, 2 µm. (B–D) Quantification of the NEBD–anaphase onset interval of embryos expressing GFP::H2b for the indicated conditions. (****) P < 0.0001 (Mann-Whitney test). (E) Model summarizing the two opposing fates of CDC-20 fluxing through the kinetochore. Microtubule attachment shifts the balance by removing the MAD-1/MAD-2 checkpoint complex and potentially also by promoting PP1c kinetochore recruitment. See also Supplemental Figure S5.

Kinetochore-localized PP1c is the likely enzyme dephosphorylating CDC-20 fluxing through the kinetochore. (A, top) Schematic of KNL-1 primary structure; the PP1-binding site (SILK–RRVSF), the “MELT” repeats that recruit the BUB-1/BUB-3 complex when phosphorylated, and the mutations engineered in KNL-1 to disrupt PP1c binding (PP1c Mut) are depicted. (Bottom) Images (left) and quantification (right) of chromosomal fluorescence for BUB-1::GFP and GFP::CDC-20 in the indicated conditions. (****) P < 0.0001 (Mann-Whitney test). Bar, 2 µm. (B–D) Quantification of the NEBD–anaphase onset interval of embryos expressing GFP::H2b for the indicated conditions. (****) P < 0.0001 (Mann-Whitney test). (E) Model summarizing the two opposing fates of CDC-20 fluxing through the kinetochore. Microtubule attachment shifts the balance by removing the MAD-1/MAD-2 checkpoint complex and potentially also by promoting PP1c kinetochore recruitment. See also Supplemental Figure S5. The findings described here highlight a duality in the fate of CDC-20 that is fluxing through a specific binding site on the BUB-1/BUB-3 complex at kinetochores (Fig. 4E). When kinetochores are unattached, checkpoint kinases recruit the MAD-1/MAD-2 complex to kinetochores and catalyze conformational conversion of soluble MAD-2 into a form that binds CDC-20 to become part of the checkpoint complex that inhibits the APC/C (Fig. 4E). The ABBA motif of BUB-1 is required to deliver CDC-20 in this checkpoint signaling reaction, as its mutation abolishes checkpoint signaling without affecting MAD-1/MAD-2 recruitment. Unexpectedly, the pool of CDC-20 dynamically fluxing through the BUB-1 ABBA motif can also be dephosphorylated by kinetochore-localized PP1c to promote APC/C activation. We note that activation of CDC-20 by kinetochores accelerates but is not essential for APC/C activation either because CDC-20 is dephosphorylated in the cytoplasm or because phosphorylation kinetically slows but does not prevent APC/C activation. Thus, kinetochores act as kinetic accelerators that reverse the brake placed on APC/C activation by Cdk phosphorylation of CDC-20. As the checkpoint signaling reaction is sensitive to microtubule attachment, the choice between the two fates of CDC-20 will be attachment-regulated (Fig. 4E). Microtubule attachments remove MAD-1/MAD-2 but leave behind a substantial pool of BUB-1/BUB-3 (Jablonski et al. 1998; Kim et al. 2015); consequently, the CDC-20 cycling through the ABBA motif of BUB-1 at attached kinetochores is more likely to be dephosphorylated and promote APC/C activation. The localization profiles of kinetochore-localized phosphatases are also complex and potentially also microtubule attachment-regulated (Liu et al. 2010), which may further alter the balance of the two fates (Fig. 4E). By anchoring two opposing fates for CDC-20 at the same binding site on kinetochores and making the balance between them attachment-regulated, we speculate that chromosomes optimize mitotic duration in a “goldilocks” zone that ensures their accurate segregation while minimizing total time spent in a vulnerable cell cycle state when transcription, translation, and secretion are globally attenuated.

Materials and methods

C. elegans strains

C. elegans strains used in this study (Supplemental Tables S1, S2) were maintained at 20°C. A transposon-based strategy (Frokjaer-Jensen et al. 2008) was used to insert transgenes at a single locus in the genome. The details on strain construction are described in the Supplemental Material.

RNAi

For RNAi, dsRNAs (Supplemental Table S3) were injected into L4 worms and incubated for 40–48 h at 20°C before imaging. For double RNAi, dsRNAs were mixed in equal ratios, with a final concentration of >0.7 mg/mL for each dsRNA.

Imaging

Time-lapse imaging was performed on either a deconvolution microscope (DeltaVision Elite, Applied Precision) equipped with a CCD camera (pco.edge 5.5 sCMOS, PCO) and a 60× 1.42 NA plan apo N objective (Olympus) or an Andor Revolution XD confocal system (Andor Technology) with a spinning-disk confocal scanner unit (CSU-10, Yokogawa) mounted on an inverted microscope (Nikon, TE2000-E). Specific imaging conditions are detailed in the Supplemental Material.
  33 in total

1.  Cyclin-dependent kinase 1-dependent activation of APC/C ubiquitin ligase.

Authors:  Kazuyuki Fujimitsu; Margaret Grimaldi; Hiroyuki Yamano
Journal:  Science       Date:  2016-04-21       Impact factor: 47.728

2.  Regulated targeting of protein phosphatase 1 to the outer kinetochore by KNL1 opposes Aurora B kinase.

Authors:  Dan Liu; Mathijs Vleugel; Chelsea B Backer; Tetsuya Hori; Tatsuo Fukagawa; Iain M Cheeseman; Michael A Lampson
Journal:  J Cell Biol       Date:  2010-03-15       Impact factor: 10.539

3.  The Cdc20 homolog, FZY-1, and its interacting protein, IFY-1, are required for proper chromosome segregation in Caenorhabditis elegans.

Authors:  Risa Kitagawa; Elaine Law; Lois Tang; Ann M Rose
Journal:  Curr Biol       Date:  2002-12-23       Impact factor: 10.834

4.  The hBUB1 and hBUBR1 kinases sequentially assemble onto kinetochores during prophase with hBUBR1 concentrating at the kinetochore plates in mitosis.

Authors:  S A Jablonski; G K Chan; C A Cooke; W C Earnshaw; T J Yen
Journal:  Chromosoma       Date:  1998-12       Impact factor: 4.316

5.  Dephosphorylation of Cdc20 is required for its C-box-dependent activation of the APC/C.

Authors:  Helene Labit; Kazuyuki Fujimitsu; N Sumru Bayin; Tohru Takaki; Julian Gannon; Hiroyuki Yamano
Journal:  EMBO J       Date:  2012-06-19       Impact factor: 11.598

6.  The ABBA motif binds APC/C activators and is shared by APC/C substrates and regulators.

Authors:  Barbara Di Fiore; Norman E Davey; Anja Hagting; Daisuke Izawa; Jörg Mansfeld; Toby J Gibson; Jonathon Pines
Journal:  Dev Cell       Date:  2015-02-09       Impact factor: 12.270

Review 7.  The spindle assembly checkpoint.

Authors:  Pablo Lara-Gonzalez; Frederick G Westhorpe; Stephen S Taylor
Journal:  Curr Biol       Date:  2012-11-20       Impact factor: 10.834

8.  Microtubule binding by KNL-1 contributes to spindle checkpoint silencing at the kinetochore.

Authors:  Julien Espeut; Dhanya K Cheerambathur; Lenno Krenning; Karen Oegema; Arshad Desai
Journal:  J Cell Biol       Date:  2012-02-13       Impact factor: 10.539

9.  Single-copy insertion of transgenes in Caenorhabditis elegans.

Authors:  Christian Frøkjaer-Jensen; M Wayne Davis; Christopher E Hopkins; Blake J Newman; Jason M Thummel; Søren-Peter Olesen; Morten Grunnet; Erik M Jorgensen
Journal:  Nat Genet       Date:  2008-10-26       Impact factor: 38.330

10.  Atomic structure of the APC/C and its mechanism of protein ubiquitination.

Authors:  Leifu Chang; Ziguo Zhang; Jing Yang; Stephen H McLaughlin; David Barford
Journal:  Nature       Date:  2015-06-15       Impact factor: 49.962

View more
  20 in total

1.  Role of phosphorylation of Cdc20 in the regulation of the action of APC/C in mitosis.

Authors:  Danielle Shevah-Sitry; Shirly Miniowitz-Shemtov; Adar Teichner; Sharon Kaisari; Avram Hershko
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-24       Impact factor: 12.779

2.  PP1 phosphatases control PAR-2 localization and polarity establishment in C. elegans embryos.

Authors:  Ida Calvi; Françoise Schwager; Monica Gotta
Journal:  J Cell Biol       Date:  2022-09-09       Impact factor: 8.077

3.  The G2-to-M Transition Is Ensured by a Dual Mechanism that Protects Cyclin B from Degradation by Cdc20-Activated APC/C.

Authors:  Pablo Lara-Gonzalez; Mark W Moyle; Jacqueline Budrewicz; Jose Mendoza-Lopez; Karen Oegema; Arshad Desai
Journal:  Dev Cell       Date:  2019-10-03       Impact factor: 12.270

Review 4.  Visualizing the complex functions and mechanisms of the anaphase promoting complex/cyclosome (APC/C).

Authors:  Claudio Alfieri; Suyang Zhang; David Barford
Journal:  Open Biol       Date:  2017-11       Impact factor: 6.411

5.  TPXL-1 activates Aurora A to clear contractile ring components from the polar cortex during cytokinesis.

Authors:  Sriyash Mangal; Jennifer Sacher; Taekyung Kim; Daniel Sampaio Osório; Fumio Motegi; Ana Xavier Carvalho; Karen Oegema; Esther Zanin
Journal:  J Cell Biol       Date:  2018-01-08       Impact factor: 10.539

Review 6.  Kinase and Phosphatase Cross-Talk at the Kinetochore.

Authors:  Adrian T Saurin
Journal:  Front Cell Dev Biol       Date:  2018-06-19

Review 7.  Phosphatases in Mitosis: Roles and Regulation.

Authors:  Margarida Moura; Carlos Conde
Journal:  Biomolecules       Date:  2019-02-07

Review 8.  Interplay between Phosphatases and the Anaphase-Promoting Complex/Cyclosome in Mitosis.

Authors:  Meghna Kataria; Hiroyuki Yamano
Journal:  Cells       Date:  2019-08-02       Impact factor: 7.666

Review 9.  Mapping Mitotic Death: Functional Integration of Mitochondria, Spindle Assembly Checkpoint and Apoptosis.

Authors:  Weimei Ruan; Hong Hwa Lim; Uttam Surana
Journal:  Front Cell Dev Biol       Date:  2019-01-10

Review 10.  Protein phosphatases in the regulation of mitosis.

Authors:  Jakob Nilsson
Journal:  J Cell Biol       Date:  2018-11-16       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.